SCHEMBL30453499

SCHEMBL30453499

CC(Oc1cc(-c2ccc(N)nc2)cnc1N)c1c(Cl)ccc(F)c1Cl

nearest known ligand 0.78

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 12/20 0.78
JAK2 O60674 2/20 0.76
INPPL1 O15357 2/20 0.72
ALK Q9UM73 4/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488221 1.00 MET (0.78) METJAK2INPPL1ALK
SCHEMBL30453362 0.93 MET (0.68) METJAK2INPPL1ALK
SCHEMBL488367 0.93 MET (0.68) METJAK2INPPL1ALK
SCHEMBL17404665 0.91 MET (0.78) METJAK2ALK
SCHEMBL3113505 0.90 MET (0.77) METJAK2ALK
SCHEMBL17404664 0.90 JAK2 (0.78) METJAK2ALK
SCHEMBL487628 0.90 MET (0.80) METJAK2ALK
SCHEMBL488807 0.90 MET (0.80) METJAK2ALK
SCHEMBL488502 0.90 MET (0.80) METJAK2ALK
SCHEMBL30452848 0.90 MET (0.84) METJAK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed